Democratic presidential candidate Hillary Clinton hit hard against pharmaceutical companies with "predatory pricing," setting her sights specifically on Canadian company Valeant.

Valeant is no stranger to disapproval about its price hikes, and just last week, it was announced they are currently the target of a Securities Exchange Commission (SEC) investigation. The company has denied any wrongdoing when it comes to price gouging related to its medication.

Clinton's criticism comes in the form of a new campaign ad on her YouTube page where she pledges to wholeheartedly attack Valeant. The highlight of the ad is a personal anecdote from one woman who says she has been prescribed a brand name medication which retailed at $180 for 10 shots when she started taking it in the 1980s. Now, the ad claims, the price for the same prescription has skyrocketed to $14,700. The company in question? Valeant.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events
  • Access to other award-winning ALM websites including and

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.